造血干细胞工程正处于十字路口。
Hematopoietic stem cell engineering at a crossroads.
机构信息
Center for Cell Engineering, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
出版信息
Blood. 2012 Feb 2;119(5):1107-16. doi: 10.1182/blood-2011-09-349993. Epub 2011 Nov 17.
Abstract
The genetic engineering of hematopoietic stem cells is the basis for potentially treating a large array of hereditary and acquired diseases, and stands as the paradigm for stem cell engineering in general. Recent clinical reports support the formidable promise of this approach but also highlight the limitations of the technologies used to date, which have on occasion resulted in clonal expansion, myelodysplasia, or leukemogenesis. New research directions, predicated on improved vector designs, targeted gene delivery or the therapeutic use of pluripotent stem cells, herald the advent of safer and more effective hematopoietic stem cell therapies that may transform medical practice. In this review, we place these recent advances in perspective, emphasizing the solutions emerging from a wave of new technologies and highlighting the challenges that lie ahead.
摘要
造血干细胞的基因工程是治疗多种遗传性和获得性疾病的基础，也是干细胞工程的典范。最近的临床报告支持了这种方法的巨大潜力，但也强调了迄今为止所使用技术的局限性，这些技术有时会导致克隆扩增、骨髓增生异常或白血病发生。基于改进的载体设计、靶向基因传递或多能干细胞的治疗应用的新研究方向预示着更安全、更有效的造血干细胞治疗方法的出现，这可能会改变医学实践。在这篇综述中，我们从新的视角看待这些最新进展，强调新技术浪潮带来的解决方案，并突出未来的挑战。
相似文献
1
Hematopoietic stem cell engineering at a crossroads.造血干细胞工程正处于十字路口。
Blood. 2012 Feb 2;119(5):1107-16. doi: 10.1182/blood-2011-09-349993. Epub 2011 Nov 17.
2
Latest development in viral vectors for gene therapy.基因治疗中病毒载体的最新进展。
Trends Biotechnol. 2003 Mar;21(3):117-22. doi: 10.1016/S0167-7799(02)00042-2.
3
Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease.基因向造血干细胞的转移：对人类疾病基因治疗的意义。
Annu Rev Med. 1996;47:11-20. doi: 10.1146/annurev.med.47.1.11.
4
Gene transfer into hematopoietic progenitor and stem cells: progress and problems.基因导入造血祖细胞和干细胞：进展与问题
Stem Cells. 1994 Nov;12(6):563-76. doi: 10.1002/stem.5530120604.
5
Retroviral vector-mediated gene transfer into hematopoietic cells: prospects and issues.逆转录病毒载体介导的基因转移至造血细胞：前景与问题
J Hematother. 1992 Summer;1(2):155-66. doi: 10.1089/scd.1.1992.1.155.
6
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned.造血干细胞基因治疗：进展与经验教训。
Cell Stem Cell. 2017 Nov 2;21(5):574-590. doi: 10.1016/j.stem.2017.10.010.
7
Promises and Challenges in Hematopoietic Stem Cell Gene Therapy.造血干细胞基因治疗的前景与挑战。
Hum Gene Ther. 2017 Oct;28(10):782-799. doi: 10.1089/hum.2017.141.
8
Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells.转基因造血干细胞的制造与移植中的问题。
Curr Opin Hematol. 2000 Nov;7(6):364-77. doi: 10.1097/00062752-200011000-00008.
9
Retroviral transfer of multidrug transporter to murine hematopoietic stem cells.多药转运蛋白向小鼠造血干细胞的逆转录病毒转移。
Methods Enzymol. 1998;292:546-57. doi: 10.1016/s0076-6879(98)92043-2.
10
Stem cell engineering for the treatment of severe hemoglobinopathies.用于治疗重度血红蛋白病的干细胞工程。
Curr Mol Med. 2008 Nov;8(7):690-7. doi: 10.2174/156652408786241357.
引用本文的文献
1
Turning "trashed" genomic loci into treasurable sites for integrating chimeric antigen receptors in T and NK cells.将“废弃”的基因组位点转化为用于在T细胞和自然杀伤细胞中整合嵌合抗原受体的宝贵位点。
Mol Ther. 2025 Apr 2;33(4):1368-1379. doi: 10.1016/j.ymthe.2025.02.028. Epub 2025 Feb 20.
2
Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.脑肾上腺脑白质营养不良基因治疗后的血液系统癌症。
N Engl J Med. 2024 Oct 10;391(14):1287-1301. doi: 10.1056/NEJMoa2405541.
3
Megakaryocyte membrane-wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells.用于将靶向货物递送至造血干细胞和祖细胞的巨核细胞膜包裹纳米颗粒。
Bioeng Transl Med. 2022 Nov 29;8(3):e10456. doi: 10.1002/btm2.10456. eCollection 2023 May.
4
Development and clinical advancement of small molecules for expansion of hematopoietic stem cell.用于扩增造血干细胞的小分子的研发与临床进展。
Acta Pharm Sin B. 2022 Jun;12(6):2808-2831. doi: 10.1016/j.apsb.2021.12.006. Epub 2021 Dec 17.
5
Current status of beta-thalassemia and its treatment strategies.β-地中海贫血的现状及其治疗策略。
Mol Genet Genomic Med. 2021 Dec;9(12):e1788. doi: 10.1002/mgg3.1788. Epub 2021 Nov 5.
6
Enhort: a platform for deep analysis of genomic positions.Enhort：一个用于基因组位置深度分析的平台。
PeerJ Comput Sci. 2019 Jun 10;5:e198. doi: 10.7717/peerj-cs.198. eCollection 2019.
7
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.嵌合抗原受体修饰的不变自然杀伤 T 细胞治疗多发性骨髓瘤的临床前评价
Int J Mol Sci. 2021 Jan 22;22(3):1096. doi: 10.3390/ijms22031096.
8
Analysis of Hematopoietic Stem Progenitor Cell Metabolism.造血干祖细胞代谢分析
J Vis Exp. 2019 Nov 9(153). doi: 10.3791/60234.
9
Gene Therapy For Beta-Thalassemia: Updated Perspectives.β地中海贫血的基因治疗：最新观点
Appl Clin Genet. 2019 Sep 23;12:167-180. doi: 10.2147/TACG.S178546. eCollection 2019.
10
Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction.癌症患者中CAR T细胞的成像：为治疗监测和结果预测铺平道路。
J Nucl Med. 2019 Jul;60(7):879-881. doi: 10.2967/jnumed.119.227561. Epub 2019 May 3.
本文引用的文献
1
Safe harbours for the integration of new DNA in the human genome.人类基因组中新 DNA 整合的安全港。
Nat Rev Cancer. 2011 Dec 1;12(1):51-8. doi: 10.1038/nrc3179.
2
Eliminating cells gone astray.清除误入歧途的细胞。
N Engl J Med. 2011 Nov 3;365(18):1735-7. doi: 10.1056/NEJMe1109971.
3
Inducible apoptosis as a safety switch for adoptive cell therapy.诱导细胞凋亡作为过继细胞治疗的安全开关。
N Engl J Med. 2011 Nov 3;365(18):1673-83. doi: 10.1056/NEJMoa1106152.
4
Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding.利用高通量测序结合病毒遗传条形码技术在体内追踪单个造血干细胞。
Nat Biotechnol. 2011 Oct 2;29(10):928-33. doi: 10.1038/nbt.1977.
5
Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.腺苷脱氨酶缺乏症严重联合免疫缺陷症的造血干细胞基因治疗可实现长期免疫恢复和代谢纠正。
Sci Transl Med. 2011 Aug 24;3(97):97ra80. doi: 10.1126/scitranslmed.3002716.
6
Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.基因治疗 X 连锁重症联合免疫缺陷后多克隆 T 细胞 repertoire 的长期持久性。
Sci Transl Med. 2011 Aug 24;3(97):97ra79. doi: 10.1126/scitranslmed.3002715.
7
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy.经γ逆转录病毒载体基因治疗后，植入细胞中的插入位点在基因组的有限区域内聚集。
Mol Ther. 2011 Nov;19(11):2031-9. doi: 10.1038/mt.2011.178. Epub 2011 Aug 23.
8
Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection.通过体外筛选揭示锌指核酸酶的脱靶切割特异性。
Nat Methods. 2011 Aug 7;8(9):765-70. doi: 10.1038/nmeth.1670.
9
An unbiased genome-wide analysis of zinc-finger nuclease specificity.锌指核酸酶特异性的无偏基因组分析。
Nat Biotechnol. 2011 Aug 7;29(9):816-23. doi: 10.1038/nbt.1948.
10
In vivo genome editing restores haemostasis in a mouse model of haemophilia.体内基因组编辑恢复血友病小鼠模型的止血功能。
Nature. 2011 Jun 26;475(7355):217-21. doi: 10.1038/nature10177.
Zotero 插件